Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

International HIV Antiretroviral Adherence, Resistance and Survival (UARTO)

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2015 by Massachusetts General Hospital
Sponsor:
Collaborators:
University of California, San Francisco
Department of Health and Human Services
Mbarara University of Science and Technology
University of British Columbia
Dana-Farber Cancer Institute
Information provided by (Responsible Party):
David Bangsberg, MD, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01596322
First received: April 22, 2010
Last updated: April 6, 2015
Last verified: April 2015